Head and neck cancer risk calculator (HaNC-RC)-V.2. Adjustments and addition of symptoms and social history factors
- PMID: 31985180
- PMCID: PMC7318185
- DOI: 10.1111/coa.13511
Head and neck cancer risk calculator (HaNC-RC)-V.2. Adjustments and addition of symptoms and social history factors
Abstract
Objectives: Head and neck cancer (HNC) diagnosis through the 2-week wait, urgent suspicion of cancer (USOC) pathway has failed to increase early cancer detection rates in the UK. A head and neck cancer risk calculator (HaNC-RC) has previously been designed to aid referral of high-risk patients to USOC clinics (predictive power: 77%). Our aim was to refine the HaNC-RC to increase its prediction potential.
Design: Following sample size calculation, prospective data collection and statistical analysis of referral criteria and outcomes.
Setting: Large tertiary care cancer centre in Scotland.
Participants: 3531 new patients seen in routine, urgent and USOC head and neck (HaN) clinics.
Main outcome measures: Data collected were as follows: demographics, social history, presenting symptoms and signs and HNC diagnosis. Univariate and multivariate regression analysis were performed to identify significant predictors of HNC. Internal validation was performed using 1000 sample bootstrapping to estimate model diagnostics included the area under the receiver operator curve (AUC), sensitivity and specificity.
Results: The updated version of the risk calculator (HaNC-RC v.2) includes age, gender, unintentional weight loss, smoking, alcohol, positive and negative symptoms and signs of HNC. It has achieved an AUC of 88.6% with two recommended triage referral cut-offs to USOC (cut-off: 7.1%; sensitivity: 85%, specificity: 78.3%) or urgent clinics (cut-off: 2.2%; sensitivity: 97.1%; specificity of 52.9%). This could redistribute cancer detection through USOC clinics from the current 60.9%-85.2%, without affecting total numbers seen in each clinical setting.
Conclusions: The use of the HaNC-RC v.2 has a significant potential in both identifying patients at high risk of HNC early thought USOC clinics but also improving health service delivery practices by reducing the number of inappropriately urgent referrals.
Keywords: diagnosis; head and neck cancer; pathway; referral; risk calculator.
© 2020 The Authors. Clinical Otolaryngology published by John Wiley & Sons Ltd.
Conflict of interest statement
None.
Similar articles
-
Accuracy of the Head and Neck Cancer Risk Calculator in identifying maxillofacial malignancies.Br J Oral Maxillofac Surg. 2023 Jun;61(5):356-361. doi: 10.1016/j.bjoms.2023.04.001. Epub 2023 Apr 23. Br J Oral Maxillofac Surg. 2023. PMID: 37169617
-
Head and neck cancer: A 6-year retrospective analysis and review of three common triaging systems.Clin Otolaryngol. 2023 Jul;48(4):630-637. doi: 10.1111/coa.14057. Epub 2023 Mar 28. Clin Otolaryngol. 2023. PMID: 36977627 Review.
-
Deprivation in relation to urgent suspicion of head and neck cancer referrals in Glasgow.Clin Otolaryngol. 2018 Jun;43(3):861-867. doi: 10.1111/coa.13077. Epub 2018 Mar 7. Clin Otolaryngol. 2018. PMID: 29380938
-
Implementation of the Symptom Based Risk Calculator for Head and Neck Cancer HaNC-RC v.2 Post COVID-19 Pandemic. A Single Centre Audit.Indian J Otolaryngol Head Neck Surg. 2024 Apr;76(2):1791-1795. doi: 10.1007/s12070-023-04412-x. Epub 2023 Dec 4. Indian J Otolaryngol Head Neck Surg. 2024. PMID: 38566700 Free PMC article.
-
Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.J Cancer Surviv. 2018 Aug;12(4):479-494. doi: 10.1007/s11764-018-0687-7. Epub 2018 Mar 20. J Cancer Surviv. 2018. PMID: 29556926
Cited by
-
Nomenclature of the symptoms of head and neck cancer: a systematic scoping review.Front Oncol. 2024 Jun 17;14:1404860. doi: 10.3389/fonc.2024.1404860. eCollection 2024. Front Oncol. 2024. PMID: 38952557 Free PMC article.
-
Remote triaging of urgent suspected head and neck cancer referrals: our experience during the first wave of the COVID-19 pandemic.Eur Arch Otorhinolaryngol. 2022 Feb;279(2):1111-1115. doi: 10.1007/s00405-021-07135-3. Epub 2021 Oct 18. Eur Arch Otorhinolaryngol. 2022. PMID: 34661717 Free PMC article.
-
The impact of 2 weeks wait referral on survival of head and neck cancer patients.Eur Arch Otorhinolaryngol. 2023 Dec;280(12):5557-5564. doi: 10.1007/s00405-023-08152-0. Epub 2023 Aug 1. Eur Arch Otorhinolaryngol. 2023. PMID: 37526700 Free PMC article.
-
Patient Satisfaction With the Head and Neck Cancer Telephone Triage Service During the COVID-19 Pandemic.Cureus. 2021 Sep 29;13(9):e18375. doi: 10.7759/cureus.18375. eCollection 2021 Sep. Cureus. 2021. PMID: 34729263 Free PMC article.
-
Rapid implementation of an evidence-based remote triaging system for assessment of suspected referrals and patients with head and neck cancer on follow-up after treatment during the COVID-19 pandemic: Model for international collaboration.Head Neck. 2020 Jul;42(7):1674-1680. doi: 10.1002/hed.26219. Epub 2020 May 11. Head Neck. 2020. PMID: 32374942 Free PMC article.
References
-
- Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE‐4 study. Lancet Oncol. 2007;8(9):773‐783. Erratum. In: Lancet Oncol. 2007;8(10):868. Bielska‐Lasota, Magdalena. - PubMed
-
- De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5‐a population‐based study. Lancet Oncol. 2014;15(1):23‐34. - PubMed
-
- Internal data analysis of Cancer Incidence Statistics for England in 2015 . Office for national statistics. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/.... Accessed June 3, 2019.
-
- Northern Ireland Cancer Registry . Northern Ireland Cancer Registry, Queens University Belfast, Incidence by stage 2010‐2014. Belfast: NICR; 2016.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical